|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
190 a.a.
|
 |
|
|
|
|
|
|
|
189 a.a.
|
 |
|
|
|
|
|
|
|
339 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Complex (lyase/hydrolase)
|
 |
|
Title:
|
 |
Complex of gs-alpha with the catalytic domains of mammalian adenylyl cyclase
|
|
Structure:
|
 |
Vc1. Chain: a. Fragment: c1a domain of adenylyl cyclase. Engineered: yes. Mutation: yes. Iic2. Chain: b. Fragment: c2a domain of adenylyl cyclase. Engineered: yes.
|
|
Source:
|
 |
Canis lupus familiaris. Dog. Organism_taxid: 9615. Strain: familiaris. Organ: plasma. Tissue: cardiac muscle. Cellular_location: plasma membrane. Gene: adenylyl cyclase type v. Expressed in: escherichia coli bl21(de3).
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.219
|
R-free:
|
0.282
|
|
|
Authors:
|
 |
J.J.G.Tesmer,S.R.Sprang
|
Key ref:
|
 |
J.J.Tesmer
et al.
(1997).
Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS.
Science,
278,
1907-1916.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-Nov-97
|
Release date:
|
25-Feb-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P30803
(ADCY5_CANFA) -
Adenylate cyclase type 5
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1265 a.a.
190 a.a.*
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.4.6.1.1
- Adenylate cyclase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP = 3',5'-cyclic AMP + diphosphate
|
 |
 |
 |
 |
 |
ATP
Bound ligand (Het Group name = )
matches with 90.00% similarity
|
=
|
3',5'-cyclic AMP
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Pyridoxal 5'-phosphate
|
 |
 |
 |
 |
 |
Pyridoxal 5'-phosphate
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
5 terms
|
 |
|
Biological process
|
intracellular signal transduction
|
25 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
10 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Science
278:1907-1916
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS.
|
|
J.J.Tesmer,
R.K.Sunahara,
A.G.Gilman,
S.R.Sprang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of a soluble, catalytically active form of adenylyl
cyclase in a complex with its stimulatory heterotrimeric G protein alpha subunit
(Gsalpha) and forskolin was determined to a resolution of 2.3 angstroms. When
P-site inhibitors were soaked into native crystals of the complex, the active
site of adenylyl cyclase was located and structural elements important for
substrate recognition and catalysis were identified. On the basis of these and
other structures, a molecular mechanism is proposed for the activation of
adenylyl cyclase by Gsalpha.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Architecture of the heterodimeric complex between
VC[1] (mauve) and IIC[2] (khaki) bound to the forskolin analog
MPFsk, as observed^ in the complex with G[s][ ]·GTP
S. (A)
View along the pseudo-twofold^ axis toward the ventral surface
of VC[1]·IIC[2]. The forskolin derivative^ is shown as a
stick figure: carbon, gray; nitrogen, cyan; and^ oxygen, red. N
and C mark the first and last ordered residues^ in the crystal
structure of the heterodimer. (B) VC[1] is^ depicted
side-by-side with a molecule of IIC[2] that has been
superimposed^ on VC[1] (rmsd of 1.3 Å for 153 C atom
pairs). Elements of secondary^ structure are labeled; in all of
the figures, the color of the^ label identifies the protein
subunit to which it refers. (C)^ Stereo diagram of the
VC[1]·IIC[2] interface, with the C backbone^
depicted as a continuous tube. The view is the same as in (A).^
Ball-and-stick models of C  C bonds are
shown for residues (50)^ that participate in interdomain
contacts (separated by less than^ 4 Å from an atom in the
opposite domain). These residues constitute^ the subset of
interfacial residues that are conserved in all adenylyl^ cyclase
isoforms. C atoms of
residues with acidic side chains^ are red, basic residues are
blue, and residues with polar side^ chains are pink. The C atoms of
nonpolar residues are khaki (VC[1])^ or mauve (IIC[2]). Dashed
gray lines show interdomain side chain-side^ chain or side
chain-main chain hydrogen bonds or ion pairs involving^ polar
or charged interfacial residues. Only the polar or charged^
residues are labeled.
|
 |
Figure 3.
Fig. 3. Only one molecule of forskolin binds in the ventral
cleft of VC[1]·IIC[2]. MPFsk binds in the ventral cleft
of adenylyl cyclase^ at the end closest to the G[s][ ]binding
site and is drawn in^ green without its methyl-piperazino group
for clarity. Residues^ constituting the forskolin binding site
of the IIC[2] homodimer^ (14) that differ from their equivalents
in the binding site^ of VC[1]·IIC[2] are drawn in
transparent rose (50). The side chain^ of Trp^1020 is also shown
because its side chain adopts a dramatically different^
conformation from that of Trp^507 in the VC[1]·IIC[2]
heterodimer. To generate this figure, we superimposed^ one of
the forskolin molecules from the IIC[2] homodimer with MPFsk;^
this superposition does not optimally align the protein
subunits^ of each structure.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the AAAs:
Science
(1997,
278,
1907-1916)
copyright 1997.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Buck,
and
L.R.Levin
(2011).
Physiological Sensing of Carbon Dioxide/Bicarbonate/pH via Cyclic Nucleotide Signaling.
|
| |
Sensors Basel Sensors, 11,
2112-2128.
|
 |
|
|
|
|
 |
K.S.Misono,
J.S.Philo,
T.Arakawa,
C.M.Ogata,
Y.Qiu,
H.Ogawa,
and
H.S.Young
(2011).
Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase.
|
| |
FEBS J, 278,
1818-1829.
|
 |
|
|
|
|
 |
L.M.Simpson,
I.D.Wall,
F.E.Blaney,
and
C.A.Reynolds
(2011).
Modeling GPCR active state conformations: The β(2) -adrenergic receptor.
|
| |
Proteins, 79,
1441-1457.
|
 |
|
|
|
|
 |
M.G.Gold,
F.Stengel,
P.J.Nygren,
C.R.Weisbrod,
J.E.Bruce,
C.V.Robinson,
D.Barford,
and
J.D.Scott
(2011).
Architecture and dynamics of an A-kinase anchoring protein 79 (AKAP79) signaling complex.
|
| |
Proc Natl Acad Sci U S A, 108,
6426-6431.
|
 |
|
|
|
|
 |
A.H.Lin,
J.E.Cohen,
Q.Wan,
K.Niu,
P.Shrestha,
S.L.Bernstein,
and
T.W.Abrams
(2010).
Serotonin stimulation of cAMP-dependent plasticity in Aplysia sensory neurons is mediated by calmodulin-sensitive adenylyl cyclase.
|
| |
Proc Natl Acad Sci U S A, 107,
15607-15612.
|
 |
|
|
|
|
 |
B.R.Temple,
C.D.Jones,
and
A.M.Jones
(2010).
Evolution of a signaling nexus constrained by protein interfaces and conformational States.
|
| |
PLoS Comput Biol, 6,
e1000962.
|
 |
|
|
|
|
 |
J.J.Tesmer
(2010).
The quest to understand heterotrimeric G protein signaling.
|
| |
Nat Struct Mol Biol, 17,
650-652.
|
 |
|
|
|
|
 |
K.Kanchan,
J.Linder,
K.Winkler,
K.Hantke,
A.Schultz,
and
J.E.Schultz
(2010).
Transmembrane signaling in chimeras of the Escherichia coli aspartate and serine chemotaxis receptors and bacterial class III adenylyl cyclases.
|
| |
J Biol Chem, 285,
2090-2099.
|
 |
|
|
|
|
 |
M.Aittaleb,
C.A.Boguth,
and
J.J.Tesmer
(2010).
Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors.
|
| |
Mol Pharmacol, 77,
111-125.
|
 |
|
|
|
|
 |
R.Budhwar,
A.Lu,
and
J.P.Hirsch
(2010).
Nutrient control of yeast PKA activity involves opposing effects on phosphorylation of the Bcy1 regulatory subunit.
|
| |
Mol Biol Cell, 21,
3749-3758.
|
 |
|
|
|
|
 |
B.Pavan,
C.Biondi,
and
A.Dalpiaz
(2009).
Adenylyl cyclases as innovative therapeutic goals.
|
| |
Drug Discov Today, 14,
982-991.
|
 |
|
|
|
|
 |
C.L.Hu,
R.Chandra,
H.Ge,
J.Pain,
L.Yan,
G.Babu,
C.Depre,
K.Iwatsubo,
Y.Ishikawa,
J.Sadoshima,
S.F.Vatner,
and
D.E.Vatner
(2009).
Adenylyl cyclase type 5 protein expression during cardiac development and stress.
|
| |
Am J Physiol Heart Circ Physiol, 297,
H1776-H1782.
|
 |
|
|
|
|
 |
C.Pinto,
M.Hübner,
A.Gille,
M.Richter,
T.C.Mou,
S.R.Sprang,
and
R.Seifert
(2009).
Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs.
|
| |
Biochem Pharmacol, 78,
62-69.
|
 |
|
|
|
|
 |
D.A.Macdougall,
S.Wachten,
A.Ciruela,
A.Sinz,
and
D.M.Cooper
(2009).
Separate elements within a single IQ-like motif in adenylyl cyclase type 8 impart ca2+/calmodulin binding and autoinhibition.
|
| |
J Biol Chem, 284,
15573-15588.
|
 |
|
|
|
|
 |
G.Halnes,
E.Ulfhielm,
E.Eklöf Ljunggren,
J.H.Kotaleski,
and
J.P.Rospars
(2009).
Modelling and sensitivity analysis of the reactions involving receptor, G-protein and effector in vertebrate olfactory receptor neurons.
|
| |
J Comput Neurosci, 27,
471-491.
|
 |
|
|
|
|
 |
H.E.Hamm,
S.M.Meier,
G.Liao,
and
A.M.Preininger
(2009).
Trp fluorescence reveals an activation-dependent cation-pi interaction in the Switch II region of Galphai proteins.
|
| |
Protein Sci, 18,
2326-2335.
|
 |
|
|
|
|
 |
J.H.Won,
and
S.H.Ghil
(2009).
The GTPase domain of Galphao contributes to the functional interaction of Galphao with the promyelocytic leukemia zinc finger protein.
|
| |
Cell Mol Biol Lett, 14,
46-56.
|
 |
|
|
|
|
 |
J.Wang,
P.Sengupta,
Y.Guo,
U.Golebiewska,
and
S.Scarlata
(2009).
Evidence for a second, high affinity Gbetagamma binding site on Galphai1(GDP) subunits.
|
| |
J Biol Chem, 284,
16906-16913.
|
 |
|
|
|
|
 |
J.Wang,
U.Golebiewska,
and
S.Scarlata
(2009).
A self-scaffolding model for G protein signaling.
|
| |
J Mol Biol, 387,
92.
|
 |
|
|
|
|
 |
K.H.Biswas,
A.R.Shenoy,
A.Dutta,
and
S.S.Visweswariah
(2009).
The evolution of guanylyl cyclases as multidomain proteins: conserved features of kinase-cyclase domain fusions.
|
| |
J Mol Evol, 68,
587-602.
|
 |
|
|
|
|
 |
K.Khafizov
(2009).
GoLoco motif proteins binding to Galpha(i1): insights from molecular simulations.
|
| |
J Mol Model, 15,
1491-1499.
|
 |
|
|
|
|
 |
M.H.Gao,
A.Miyanohara,
J.R.Feramisco,
and
T.Tang
(2009).
Activation of PH-domain leucine-rich protein phosphatase 2 (PHLPP2) by agonist stimulation in cardiac myocytes expressing adenylyl cyclase type 6.
|
| |
Biochem Biophys Res Commun, 384,
193-198.
|
 |
|
|
|
|
 |
M.Pagano,
M.A.Clynes,
N.Masada,
A.Ciruela,
L.J.Ayling,
S.Wachten,
and
D.M.Cooper
(2009).
Insights into the residence in lipid rafts of adenylyl cyclase AC8 and its regulation by capacitative calcium entry.
|
| |
Am J Physiol Cell Physiol, 296,
C607-C619.
|
 |
|
|
|
|
 |
N.V.Valeyev,
P.Heslop-Harrison,
I.Postlethwaite,
A.N.Gizatullina,
N.V.Kotov,
and
D.G.Bates
(2009).
Crosstalk between G-protein and Ca2+ pathways switches intracellular cAMP levels.
|
| |
Mol Biosyst, 5,
43-51.
|
 |
|
|
|
|
 |
P.Lupieri,
C.H.Nguyen,
Z.G.Bafghi,
A.Giorgetti,
and
P.Carloni
(2009).
Computational molecular biology approaches to ligand-target interactions.
|
| |
HFSP J, 3,
228-239.
|
 |
|
|
|
|
 |
R.Sadana,
and
C.W.Dessauer
(2009).
Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.
|
| |
Neurosignals, 17,
5.
|
 |
|
|
|
|
 |
S.Pierre,
T.Eschenhagen,
G.Geisslinger,
and
K.Scholich
(2009).
Capturing adenylyl cyclases as potential drug targets.
|
| |
Nat Rev Drug Discov, 8,
321-335.
|
 |
|
|
|
|
 |
S.Saha,
K.H.Biswas,
C.Kondapalli,
N.Isloor,
and
S.S.Visweswariah
(2009).
The linker region in receptor guanylyl cyclases is a key regulatory module: mutational analysis of guanylyl cyclase C.
|
| |
J Biol Chem, 284,
27135-27145.
|
 |
|
|
|
|
 |
S.Suryanarayana,
M.Göttle,
M.Hübner,
A.Gille,
T.C.Mou,
S.R.Sprang,
M.Richter,
and
R.Seifert
(2009).
Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates.
|
| |
J Pharmacol Exp Ther, 330,
687-695.
|
 |
|
|
|
|
 |
T.C.Mou,
N.Masada,
D.M.Cooper,
and
S.R.Sprang
(2009).
Structural basis for inhibition of mammalian adenylyl cyclase by calcium.
|
| |
Biochemistry, 48,
3387-3397.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.E.McIntire
(2009).
Structural determinants involved in the formation and activation of G protein betagamma dimers.
|
| |
Neurosignals, 17,
82-99.
|
 |
|
|
|
|
 |
W.J.Tang,
and
Q.Guo
(2009).
The adenylyl cyclase activity of anthrax edema factor.
|
| |
Mol Aspects Med, 30,
423-430.
|
 |
|
|
|
|
 |
W.S.Sossin,
and
T.W.Abrams
(2009).
Evolutionary conservation of the signaling proteins upstream of cyclic AMP-dependent kinase and protein kinase C in gastropod mollusks.
|
| |
Brain Behav Evol, 74,
191-205.
|
 |
|
|
|
|
 |
A.Goc,
T.E.Angel,
B.Jastrzebska,
B.Wang,
P.L.Wintrode,
and
K.Palczewski
(2008).
Different properties of the native and reconstituted heterotrimeric G protein transducin.
|
| |
Biochemistry, 47,
12409-12419.
|
 |
|
|
|
|
 |
A.R.Zurita,
and
L.Birnbaumer
(2008).
The same mutation in Gsalpha and transducin alpha reveals behavioral differences between these highly homologous G protein alpha-subunits.
|
| |
Proc Natl Acad Sci U S A, 105,
2363-2368.
|
 |
|
|
|
|
 |
A.Rauch,
M.Leipelt,
M.Russwurm,
and
C.Steegborn
(2008).
Crystal structure of the guanylyl cyclase Cya2.
|
| |
Proc Natl Acad Sci U S A, 105,
15720-15725.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Shankaranarayanan,
D.M.Thal,
V.M.Tesmer,
D.L.Roman,
R.R.Neubig,
T.Kozasa,
and
J.J.Tesmer
(2008).
Assembly of high order G alpha q-effector complexes with RGS proteins.
|
| |
J Biol Chem, 283,
34923-34934.
|
 |
|
|
|
|
 |
A.V.Smrcka,
D.M.Lehmann,
and
A.L.Dessal
(2008).
G protein betagamma subunits as targets for small molecule therapeutic development.
|
| |
Comb Chem High Throughput Screen, 11,
382-395.
|
 |
|
|
|
|
 |
C.A.Johnston,
K.Afshar,
J.T.Snyder,
G.G.Tall,
P.Gönczy,
D.P.Siderovski,
and
F.S.Willard
(2008).
Structural determinants underlying the temperature-sensitive nature of a Galpha mutant in asymmetric cell division of Caenorhabditis elegans.
|
| |
J Biol Chem, 283,
21550-21558.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.McCusker,
and
A.S.Robinson
(2008).
Refolding of G protein alpha subunits from inclusion bodies expressed in Escherichia coli.
|
| |
Protein Expr Purif, 58,
342-355.
|
 |
|
|
|
|
 |
J.A.Winger,
E.R.Derbyshire,
M.H.Lamers,
M.A.Marletta,
and
J.Kuriyan
(2008).
The crystal structure of the catalytic domain of a eukaryotic guanylate cyclase.
|
| |
BMC Struct Biol, 8,
42.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.J.Tesmer
(2008).
Guanylyl cyclase sees the light.
|
| |
J Biol, 7,
31.
|
 |
|
|
|
|
 |
J.L.Wacker,
D.B.Feller,
X.B.Tang,
M.C.Defino,
Y.Namkung,
J.S.Lyssand,
A.J.Mhyre,
X.Tan,
J.B.Jensen,
and
C.Hague
(2008).
Disease-causing mutation in GPR54 reveals the importance of the second intracellular loop for class A G-protein-coupled receptor function.
|
| |
J Biol Chem, 283,
31068-31078.
|
 |
|
|
|
|
 |
J.U.Linder,
and
J.E.Schultz
(2008).
Versatility of signal transduction encoded in dimeric adenylyl cyclases.
|
| |
Curr Opin Struct Biol, 18,
667-672.
|
 |
|
|
|
|
 |
K.Manikandan,
D.Pal,
S.Ramakumar,
N.E.Brener,
S.S.Iyengar,
and
G.Seetharaman
(2008).
Functionally important segments in proteins dissected using Gene Ontology and geometric clustering of peptide fragments.
|
| |
Genome Biol, 9,
R52.
|
 |
|
|
|
|
 |
N.De,
M.Pirruccello,
P.V.Krasteva,
N.Bae,
R.V.Raghavan,
and
H.Sondermann
(2008).
Phosphorylation-independent regulation of the diguanylate cyclase WspR.
|
| |
PLoS Biol, 6,
e67.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Venkataraman,
T.Duda,
S.Ravichandran,
and
R.K.Sharma
(2008).
Neurocalcin delta modulation of ROS-GC1, a new model of Ca(2+) signaling.
|
| |
Biochemistry, 47,
6590-6601.
|
 |
|
|
|
|
 |
X.Ma,
N.Sayed,
P.Baskaran,
A.Beuve,
and
F.van den Akker
(2008).
PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure.
|
| |
J Biol Chem, 283,
1167-1178.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Chen,
T.K.Janganan,
G.Chen,
E.R.Marques,
M.R.Kress,
G.H.Goldman,
A.R.Walmsley,
and
M.I.Borges-Walmsley
(2007).
The cAMP pathway is important for controlling the morphological switch to the pathogenic yeast form of Paracoccidioides brasiliensis.
|
| |
Mol Microbiol, 65,
761-779.
|
 |
|
|
|
|
 |
D.Guo,
Y.C.Tan,
D.Wang,
K.S.Madhusoodanan,
Y.Zheng,
T.Maack,
J.J.Zhang,
and
X.Y.Huang
(2007).
A Rac-cGMP signaling pathway.
|
| |
Cell, 128,
341-355.
|
 |
|
|
|
|
 |
F.Mancia,
and
W.A.Hendrickson
(2007).
Expression of recombinant G-protein coupled receptors for structural biology.
|
| |
Mol Biosyst, 3,
723-734.
|
 |
|
|
|
|
 |
H.Liu,
A.Suresh,
F.S.Willard,
D.P.Siderovski,
S.Lu,
and
N.I.Naqvi
(2007).
Rgs1 regulates multiple Galpha subunits in Magnaporthe pathogenesis, asexual growth and thigmotropism.
|
| |
EMBO J, 26,
690-700.
|
 |
|
|
|
|
 |
J.L.Wang,
J.X.Guo,
Q.Y.Zhang,
J.J.Wu,
R.Seifert,
and
G.H.Lushington
(2007).
A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.
|
| |
Bioorg Med Chem, 15,
2993-3002.
|
 |
|
|
|
|
 |
J.M.Cunliffe,
M.R.Whorton,
R.K.Sunahara,
and
R.T.Kennedy
(2007).
A CE assay for the detection of agonist-stimulated adenylyl cyclase activity.
|
| |
Electrophoresis, 28,
1913-1920.
|
 |
|
|
|
|
 |
L.S.Weinstein,
T.Xie,
Q.H.Zhang,
and
M.Chen
(2007).
Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology.
|
| |
Pharmacol Ther, 115,
271-291.
|
 |
|
|
|
|
 |
N.Muja,
J.K.Nelson,
and
G.H.DeVries
(2007).
Schwann cells express IP prostanoid receptors coupled to an elevation in intracellular cyclic AMP.
|
| |
J Neurosci Res, 85,
1159-1169.
|
 |
|
|
|
|
 |
P.Block,
N.Weskamp,
A.Wolf,
and
G.Klebe
(2007).
Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.
|
| |
Proteins, 68,
170-186.
|
 |
|
|
|
|
 |
R.B.Russell
(2007).
Classification of protein folds.
|
| |
Mol Biotechnol, 36,
238-247.
|
 |
|
|
|
|
 |
W.M.Oldham,
N.Van Eps,
A.M.Preininger,
W.L.Hubbell,
and
H.E.Hamm
(2007).
Mapping allosteric connections from the receptor to the nucleotide-binding pocket of heterotrimeric G proteins.
|
| |
Proc Natl Acad Sci U S A, 104,
7927-7932.
|
 |
|
|
|
|
 |
X.Liang,
D.J.Campopiano,
and
P.J.Sadler
(2007).
Metals in membranes.
|
| |
Chem Soc Rev, 36,
968-992.
|
 |
|
|
|
|
 |
X.Ma,
N.Sayed,
A.Beuve,
and
F.van den Akker
(2007).
NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism.
|
| |
EMBO J, 26,
578-588.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Zheng,
D.Xu,
and
X.Gu
(2007).
Functional divergence after gene duplication and sequence-structure relationship: a case study of G-protein alpha subunits.
|
| |
J Exp Zoolog B Mol Dev Evol, 308,
85-96.
|
 |
|
|
|
|
 |
B.Kreutz,
D.M.Yau,
M.R.Nance,
S.Tanabe,
J.J.Tesmer,
and
T.Kozasa
(2006).
A new approach to producing functional G alpha subunits yields the activated and deactivated structures of G alpha(12/13) proteins.
|
| |
Biochemistry, 45,
167-174.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.A.Johnston,
E.S.Lobanova,
A.S.Shavkunov,
J.Low,
J.K.Ramer,
R.Blaesius,
Z.Fredericks,
F.S.Willard,
B.Kuhlman,
V.Y.Arshavsky,
and
D.P.Siderovski
(2006).
Minimal determinants for binding activated G alpha from the structure of a G alpha(i1)-peptide dimer.
|
| |
Biochemistry, 45,
11390-11400.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Marchand,
S.Antony,
K.W.Kohn,
M.Cushman,
A.Ioanoviciu,
B.L.Staker,
A.B.Burgin,
L.Stewart,
and
Y.Pommier
(2006).
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.
|
| |
Mol Cancer Ther, 5,
287-295.
|
 |
|
|
|
|
 |
M.Yoshimura,
S.Pearson,
Y.Kadota,
and
C.E.Gonzalez
(2006).
Identification of ethanol responsive domains of adenylyl cyclase.
|
| |
Alcohol Clin Exp Res, 30,
1824-1832.
|
 |
|
|
|
|
 |
O.V.Evgenov,
P.Pacher,
P.M.Schmidt,
G.Haskó,
H.H.Schmidt,
and
J.P.Stasch
(2006).
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.
|
| |
Nat Rev Drug Discov, 5,
755-768.
|
 |
|
|
|
|
 |
S.K.Gibson,
and
A.G.Gilman
(2006).
Gialpha and Gbeta subunits both define selectivity of G protein activation by alpha2-adrenergic receptors.
|
| |
Proc Natl Acad Sci U S A, 103,
212-217.
|
 |
|
|
|
|
 |
S.Wachten,
J.Schlenstedt,
R.Gauss,
and
A.Baumann
(2006).
Molecular identification and functional characterization of an adenylyl cyclase from the honeybee.
|
| |
J Neurochem, 96,
1580-1590.
|
 |
|
|
|
|
 |
T.L.Poulos
(2006).
Soluble guanylate cyclase.
|
| |
Curr Opin Struct Biol, 16,
736-743.
|
 |
|
|
|
|
 |
C.A.Johnston,
F.S.Willard,
M.R.Jezyk,
Z.Fredericks,
E.T.Bodor,
M.B.Jones,
R.Blaesius,
V.J.Watts,
T.K.Harden,
J.Sondek,
J.K.Ramer,
and
D.P.Siderovski
(2005).
Structure of Galpha(i1) bound to a GDP-selective peptide provides insight into guanine nucleotide exchange.
|
| |
Structure, 13,
1069-1080.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Steegborn,
T.N.Litvin,
L.R.Levin,
J.Buck,
and
H.Wu
(2005).
Bicarbonate activation of adenylyl cyclase via promotion of catalytic active site closure and metal recruitment.
|
| |
Nat Struct Mol Biol, 12,
32-37.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Kostenis,
M.Waelbroeck,
and
G.Milligan
(2005).
Techniques: promiscuous Galpha proteins in basic research and drug discovery.
|
| |
Trends Pharmacol Sci, 26,
595-602.
|
 |
|
|
|
|
 |
F.D.Ivey,
and
C.S.Hoffman
(2005).
Direct activation of fission yeast adenylate cyclase by the Gpa2 Galpha of the glucose signaling pathway.
|
| |
Proc Natl Acad Sci U S A, 102,
6108-6113.
|
 |
|
|
|
|
 |
J.J.Tesmer
(2005).
A seminal study of soluble adenylyl cyclase.
|
| |
Nat Struct Mol Biol, 12,
7-8.
|
 |
|
|
|
|
 |
L.I.Castro,
C.Hermsen,
J.E.Schultz,
and
J.U.Linder
(2005).
Adenylyl cyclase Rv0386 from Mycobacterium tuberculosis H37Rv uses a novel mode for substrate selection.
|
| |
FEBS J, 272,
3085-3092.
|
 |
|
|
|
|
 |
M.A.Schade,
N.K.Reynolds,
C.M.Dollins,
and
K.G.Miller
(2005).
Mutations that rescue the paralysis of Caenorhabditis elegans ric-8 (synembryn) mutants activate the G alpha(s) pathway and define a third major branch of the synaptic signaling network.
|
| |
Genetics, 169,
631-649.
|
 |
|
|
|
|
 |
Q.Guo,
Y.Shen,
Y.S.Lee,
C.S.Gibbs,
M.Mrksich,
and
W.J.Tang
(2005).
Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin.
|
| |
EMBO J, 24,
3190-3201.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.C.Sinha,
M.Wetterer,
S.R.Sprang,
J.E.Schultz,
and
J.U.Linder
(2005).
Origin of asymmetry in adenylyl cyclases: structures of Mycobacterium tuberculosis Rv1900c.
|
| |
EMBO J, 24,
663-673.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Shiga,
and
N.Suzuki
(2005).
Amphipathic alpha-helix mediates the heterodimerization of soluble guanylyl cyclase.
|
| |
Zoolog Sci, 22,
735-742.
|
 |
|
|
|
|
 |
V.Bhandawat,
J.Reisert,
and
K.W.Yau
(2005).
Elementary response of olfactory receptor neurons to odorants.
|
| |
Science, 308,
1931-1934.
|
 |
|
|
|
|
 |
Y.L.Guo,
U.Kurz,
A.Schultz,
J.U.Linder,
D.Dittrich,
C.Keller,
S.Ehlers,
P.Sander,
and
J.E.Schultz
(2005).
Interaction of Rv1625c, a mycobacterial class IIIa adenylyl cyclase, with a mammalian congener.
|
| |
Mol Microbiol, 57,
667-677.
|
 |
|
|
|
|
 |
Y.Pommier,
and
J.Cherfils
(2005).
Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery.
|
| |
Trends Pharmacol Sci, 26,
138-145.
|
 |
|
|
|
|
 |
Z.Chen,
W.D.Singer,
P.C.Sternweis,
and
S.R.Sprang
(2005).
Structure of the p115RhoGEF rgRGS domain-Galpha13/i1 chimera complex suggests convergent evolution of a GTPase activator.
|
| |
Nat Struct Mol Biol, 12,
191-197.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.D.Ketkar,
A.R.Shenoy,
M.M.Kesavulu,
S.S.Visweswariah,
and
K.Suguna
(2004).
Purification, crystallization and preliminary X-ray diffraction analysis of the catalytic domain of adenylyl cyclase Rv1625c from Mycobacterium tuberculosis.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
371-373.
|
 |
|
|
|
|
 |
A.R.Shenoy,
K.Sivakumar,
A.Krupa,
N.Srinivasan,
and
S.S.Visweswariah
(2004).
A Survey of Nucleotide Cyclases in Actinobacteria: Unique Domain Organization and Expansion of the Class III Cyclase Family in Mycobacterium tuberculosis.
|
| |
Comp Funct Genomics, 5,
17-38.
|
 |
|
|
|
|
 |
D.A.Baker,
and
J.M.Kelly
(2004).
Structure, function and evolution of microbial adenylyl and guanylyl cyclases.
|
| |
Mol Microbiol, 52,
1229-1242.
|
 |
|
|
|
|
 |
D.Gai,
R.Zhao,
D.Li,
C.V.Finkielstein,
and
X.S.Chen
(2004).
Mechanisms of conformational change for a replicative hexameric helicase of SV40 large tumor antigen.
|
| |
Cell, 119,
47-60.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.R.Lazarowski,
R.Tarran,
B.R.Grubb,
C.A.van Heusden,
S.Okada,
and
R.C.Boucher
(2004).
Nucleotide release provides a mechanism for airway surface liquid homeostasis.
|
| |
J Biol Chem, 279,
36855-36864.
|
 |
|
|
|
|
 |
M.Russwurm,
and
D.Koesling
(2004).
NO activation of guanylyl cyclase.
|
| |
EMBO J, 23,
4443-4450.
|
 |
|
|
|
|
 |
S.Saran,
and
P.Schaap
(2004).
Adenylyl cyclase G is activated by an intramolecular osmosensor.
|
| |
Mol Biol Cell, 15,
1479-1486.
|
 |
|
|
|
|
 |
T.Woyke,
M.E.Berens,
D.B.Hoelzinger,
G.R.Pettit,
G.Winkelmann,
and
R.K.Pettit
(2004).
Differential gene expression in auristatin PHE-treated Cryptococcus neoformans.
|
| |
Antimicrob Agents Chemother, 48,
561-567.
|
 |
|
|
|
|
 |
Y.Shen,
N.L.Zhukovskaya,
M.I.Zimmer,
S.Soelaiman,
P.Bergson,
C.R.Wang,
C.S.Gibbs,
and
W.J.Tang
(2004).
Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.
|
| |
Proc Natl Acad Sci U S A, 101,
3242-3247.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Ksiazek,
H.Brandstetter,
L.Israel,
G.P.Bourenkov,
G.Katchalova,
K.P.Janssen,
H.D.Bartunik,
A.A.Noegel,
M.Schleicher,
and
T.A.Holak
(2003).
Structure of the N-terminal domain of the adenylyl cyclase-associated protein (CAP) from Dictyostelium discoideum.
|
| |
Structure, 11,
1171-1178.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.Sokal,
A.Alekseev,
and
K.Palczewski
(2003).
Photoreceptor guanylate cyclase variants: cGMP production under control.
|
| |
Acta Biochim Pol, 50,
1075-1095.
|
 |
|
|
|
|
 |
K.Iwatsubo,
T.Tsunematsu,
and
Y.Ishikawa
(2003).
Isoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapy.
|
| |
Expert Opin Ther Targets, 7,
441-451.
|
 |
|
|
|
|
 |
M.E.Hatley,
S.W.Lockless,
S.K.Gibson,
A.G.Gilman,
and
R.Ranganathan
(2003).
Allosteric determinants in guanine nucleotide-binding proteins.
|
| |
Proc Natl Acad Sci U S A, 100,
14445-14450.
|
 |
|
|
|
|
 |
M.Würtele,
C.Jelich-Ottmann,
A.Wittinghofer,
and
C.Oecking
(2003).
Structural view of a fungal toxin acting on a 14-3-3 regulatory complex.
|
| |
EMBO J, 22,
987-994.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.R.Shenoy,
N.Srinivasan,
and
S.S.Visweswariah
(2002).
The ascent of nucleotide cyclases: conservation and evolution of a theme.
|
| |
J Biosci, 27,
85-91.
|
 |
|
|
|
|
 |
C.Gu,
J.J.Cali,
and
D.M.Cooper
(2002).
Dimerization of mammalian adenylate cyclases.
|
| |
Eur J Biochem, 269,
413-421.
|
 |
|
|
|
|
 |
C.Moorman,
and
R.H.Plasterk
(2002).
Functional characterization of the adenylyl cyclase gene sgs-1 by analysis of a mutational spectrum in Caenorhabditis elegans.
|
| |
Genetics, 161,
133-142.
|
 |
|
|
|
|
 |
I.Sokal,
A.Alekseev,
W.Baehr,
F.Haeseleer,
and
K.Palczewski
(2002).
Soluble fusion proteins between single transmembrane photoreceptor guanylyl cyclases and their activators.
|
| |
Biochemistry, 41,
251-257.
|
 |
|
|
|
|
 |
J.A.Alspaugh,
R.Pukkila-Worley,
T.Harashima,
L.M.Cavallo,
D.Funnell,
G.M.Cox,
J.R.Perfect,
J.W.Kronstad,
and
J.Heitman
(2002).
Adenylyl cyclase functions downstream of the Galpha protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans.
|
| |
Eukaryot Cell, 1,
75-84.
|
 |
|
|
|
|
 |
J.P.Stasch,
P.Schmidt,
C.Alonso-Alija,
H.Apeler,
K.Dembowsky,
M.Haerter,
M.Heil,
T.Minuth,
E.Perzborn,
U.Pleiss,
M.Schramm,
W.Schroeder,
H.Schröder,
E.Stahl,
W.Steinke,
and
F.Wunder
(2002).
NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
|
| |
Br J Pharmacol, 136,
773-783.
|
 |
|
|
|
|
 |
J.Téllez-Sosa,
N.Soberón,
A.Vega-Segura,
M.E.Torres-Márquez,
and
M.A.Cevallos
(2002).
The Rhizobium etli cyaC product: characterization of a novel adenylate cyclase class.
|
| |
J Bacteriol, 184,
3560-3568.
|
 |
|
|
|
|
 |
L.S.Weinstein,
M.Chen,
and
J.Liu
(2002).
Gs(alpha) mutations and imprinting defects in human disease.
|
| |
Ann N Y Acad Sci, 968,
173-197.
|
 |
|
|
|
|
 |
S.Donovan,
K.M.Shannon,
and
G.Bollag
(2002).
GTPase activating proteins: critical regulators of intracellular signaling.
|
| |
Biochim Biophys Acta, 1602,
23-45.
|
 |
|
|
|
|
 |
T.Kanacher,
A.Schultz,
J.U.Linder,
and
J.E.Schultz
(2002).
A GAF-domain-regulated adenylyl cyclase from Anabaena is a self-activating cAMP switch.
|
| |
EMBO J, 21,
3672-3680.
|
 |
|
|
|
|
 |
B.Bieger,
and
L.O.Essen
(2001).
Structural analysis of adenylate cyclases from Trypanosoma brucei in their monomeric state.
|
| |
EMBO J, 20,
433-445.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Tabakoff,
E.Nelson,
M.Yoshimura,
K.Hellevuo,
and
P.L.Hoffman
(2001).
Phosphorylation cascades control the actions of ethanol on cell cAMP signalling.
|
| |
J Biomed Sci, 8,
44-51.
|
 |
|
|
|
|
 |
B.Wedel,
and
D.Garbers
(2001).
The guanylyl cyclase family at Y2K.
|
| |
Annu Rev Physiol, 63,
215-233.
|
 |
|
|
|
|
 |
C.Gu,
A.Sorkin,
and
D.M.Cooper
(2001).
Persistent interactions between the two transmembrane clusters dictate the targeting and functional assembly of adenylyl cyclase.
|
| |
Curr Biol, 11,
185-190.
|
 |
|
|
|
|
 |
C.L.Drum,
Y.Shen,
P.A.Rice,
A.Bohm,
and
W.J.Tang
(2001).
Crystallization and preliminary X-ray study of the edema factor exotoxin adenylyl cyclase domain from Bacillus anthracis in the presence of its activator, calmodulin.
|
| |
Acta Crystallogr D Biol Crystallogr, 57,
1881-1884.
|
 |
|
|
|
|
 |
C.R.Rocha,
K.Schröppel,
D.Harcus,
A.Marcil,
D.Dignard,
B.N.Taylor,
D.Y.Thomas,
M.Whiteway,
and
E.Leberer
(2001).
Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans.
|
| |
Mol Biol Cell, 12,
3631-3643.
|
 |
|
|
|
|
 |
D.K.Muhia,
C.A.Swales,
W.Deng,
J.M.Kelly,
and
D.A.Baker
(2001).
The gametocyte-activating factor xanthurenic acid stimulates an increase in membrane-associated guanylyl cyclase activity in the human malaria parasite Plasmodium falciparum.
|
| |
Mol Microbiol, 42,
553-560.
|
 |
|
|
|
|
 |
D.S.Dwyer
(2001).
Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport.
|
| |
Proteins, 42,
531-541.
|
 |
|
|
|
|
 |
J.Hanoune,
and
N.Defer
(2001).
Regulation and role of adenylyl cyclase isoforms.
|
| |
Annu Rev Pharmacol Toxicol, 41,
145-174.
|
 |
|
|
|
|
 |
J.Pei,
and
N.V.Grishin
(2001).
GGDEF domain is homologous to adenylyl cyclase.
|
| |
Proteins, 42,
210-216.
|
 |
|
|
|
|
 |
J.Roelofs,
M.Meima,
P.Schaap,
and
P.J.Van Haastert
(2001).
The Dictyostelium homologue of mammalian soluble adenylyl cyclase encodes a guanylyl cyclase.
|
| |
EMBO J, 20,
4341-4348.
|
 |
|
|
|
|
 |
M.K.Chan
(2001).
Recent advances in heme-protein sensors.
|
| |
Curr Opin Chem Biol, 5,
216-222.
|
 |
|
|
|
|
 |
Y.L.Guo,
T.Seebacher,
U.Kurz,
J.U.Linder,
and
J.E.Schultz
(2001).
Adenylyl cyclase Rv1625c of Mycobacterium tuberculosis: a progenitor of mammalian adenylyl cyclases.
|
| |
EMBO J, 20,
3667-3675.
|
 |
|
|
|
|
 |
B.Bieger,
and
L.O.Essen
(2000).
Crystallization and preliminary X-ray analysis of the catalytic domain of the adenylate cyclase GRESAG4.1 from Trypanosoma brucei.
|
| |
Acta Crystallogr D Biol Crystallogr, 56,
359-362.
|
 |
|
|
|
|
 |
F.A.Antoni
(2000).
Molecular diversity of cyclic AMP signalling.
|
| |
Front Neuroendocrinol, 21,
103-132.
|
 |
|
|
|
|
 |
H.Patel,
K.Guo,
C.Parent,
J.Gross,
P.N.Devreotes,
and
C.J.Weijer
(2000).
A temperature-sensitive adenylyl cyclase mutant of Dictyostelium.
|
| |
EMBO J, 19,
2247-2256.
|
 |
|
|
|
|
 |
J.J.Tesmer,
C.W.Dessauer,
R.K.Sunahara,
L.D.Murray,
R.A.Johnson,
A.G.Gilman,
and
S.R.Sprang
(2000).
Molecular basis for P-site inhibition of adenylyl cyclase.
|
| |
Biochemistry, 39,
14464-14471.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.Vijayachandra,
M.Guruprasad,
R.Bhandari,
U.H.Manjunath,
B.P.Somesh,
N.Srinivasan,
K.Suguna,
and
S.S.Visweswariah
(2000).
Biochemical characterization of the intracellular domain of the human guanylyl cyclase C receptor provides evidence for a catalytically active homotrimer.
|
| |
Biochemistry, 39,
16075-16083.
|
 |
|
|
|
|
 |
M.Sprinzl,
S.Brock,
Y.Huang,
P.Milovnik,
M.Nanninga,
M.Nesper-Brock,
H.Rütthard,
and
K.Szkaradkiewicz
(2000).
Regulation of GTPases in the bacterial translation machinery.
|
| |
Biol Chem, 381,
367-375.
|
 |
|
|
|
|
 |
R.A.Forse
(2000).
Biology of heterotrimeric G-protein signaling.
|
| |
Crit Care Med, 28,
N53-N59.
|
 |
|
|
|
|
 |
T.M.Glennon,
J.Villà,
and
A.Warshel
(2000).
How does GAP catalyze the GTPase reaction of Ras? A computer simulation study.
|
| |
Biochemistry, 39,
9641-9651.
|
 |
|
|
|
|
 |
V.Echeverría,
M.V.Hinrichs,
M.Torrejón,
S.Ropero,
J.Martinez,
M.J.Toro,
and
J.Olate
(2000).
Mutagenesis in the switch IV of the helical domain of the human Gsalpha reduces its GDP/GTP exchange rate.
|
| |
J Cell Biochem, 76,
368-375.
|
 |
|
|
|
|
 |
Y.C.Ma,
J.Huang,
S.Ali,
W.Lowry,
and
X.Y.Huang
(2000).
Src tyrosine kinase is a novel direct effector of G proteins.
|
| |
Cell, 102,
635-646.
|
 |
|
|
|
|
 |
A.Danchin
(1999).
From protein sequence to function.
|
| |
Curr Opin Struct Biol, 9,
363-367.
|
 |
|
|
|
|
 |
A.Friebe,
M.Russwurm,
E.Mergia,
and
D.Koesling
(1999).
A point-mutated guanylyl cyclase with features of the YC-1-stimulated enzyme: implications for the YC-1 binding site?
|
| |
Biochemistry, 38,
15253-15257.
|
 |
|
|
|
|
 |
C.Ostermeier,
and
A.T.Brunger
(1999).
Structural basis of Rab effector specificity: crystal structure of the small G protein Rab3A complexed with the effector domain of rabphilin-3A.
|
| |
Cell, 96,
363-374.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.W.Dessauer,
J.J.Tesmer,
S.R.Sprang,
and
A.G.Gilman
(1999).
The interactions of adenylate cyclases with P-site inhibitors.
|
| |
Trends Pharmacol Sci, 20,
205-210.
|
 |
|
|
|
|
 |
H.LeVine
(1999).
Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.
|
| |
Mol Neurobiol, 19,
111-149.
|
 |
|
|
|
|
 |
J.Goldberg
(1999).
Structural and functional analysis of the ARF1-ARFGAP complex reveals a role for coatomer in GTP hydrolysis.
|
| |
Cell, 96,
893-902.
|
 |
|
|
|
|
 |
J.U.Linder,
P.Engel,
A.Reimer,
T.Krüger,
H.Plattner,
A.Schultz,
and
J.E.Schultz
(1999).
Guanylyl cyclases with the topology of mammalian adenylyl cyclases and an N-terminal P-type ATPase-like domain in Paramecium, Tetrahymena and Plasmodium.
|
| |
EMBO J, 18,
4222-4232.
|
 |
|
|
|
|
 |
M.Yoshimura,
and
B.Tabakoff
(1999).
Ethanol's actions on cAMP-mediated signaling in cells transfected with type VII adenylyl cyclase.
|
| |
Alcohol Clin Exp Res, 23,
1457-1461.
|
 |
|
|
|
|
 |
M.Young,
K.Kirshenbaum,
K.A.Dill,
and
S.Highsmith
(1999).
Predicting conformational switches in proteins.
|
| |
Protein Sci, 8,
1752-1764.
|
 |
|
|
|
|
 |
R.Maesaki,
K.Ihara,
T.Shimizu,
S.Kuroda,
K.Kaibuchi,
and
T.Hakoshima
(1999).
The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1.
|
| |
Mol Cell, 4,
793-803.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.G.Sarafianos,
K.Das,
J.Ding,
P.L.Boyer,
S.H.Hughes,
and
E.Arnold
(1999).
Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site.
|
| |
Chem Biol, 6,
R137-R146.
|
 |
|
|
|
|
 |
W.F.Simonds
(1999).
G protein regulation of adenylate cyclase.
|
| |
Trends Pharmacol Sci, 20,
66-73.
|
 |
|
|
|
|
 |
A.G.Murzin
(1998).
How far divergent evolution goes in proteins.
|
| |
Curr Opin Struct Biol, 8,
380-387.
|
 |
|
|
|
|
 |
C.L.Tucker,
J.H.Hurley,
T.R.Miller,
and
J.B.Hurley
(1998).
Two amino acid substitutions convert a guanylyl cyclase, RetGC-1, into an adenylyl cyclase.
|
| |
Proc Natl Acad Sci U S A, 95,
5993-5997.
|
 |
|
|
|
|
 |
C.Schauber,
L.Chen,
P.Tongaonkar,
I.Vega,
and
K.Madura
(1998).
Sequence elements that contribute to the degradation of yeast G alpha.
|
| |
Genes Cells, 3,
307-319.
|
 |
|
|
|
|
 |
D.E.Coleman,
and
S.R.Sprang
(1998).
Crystal structures of the G protein Gi alpha 1 complexed with GDP and Mg2+: a crystallographic titration experiment.
|
| |
Biochemistry, 37,
14376-14385.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.F.Doyle,
and
D.R.Corey
(1998).
Engineering proteins: keeping up with biology.
|
| |
Chem Biol, 5,
R157-R160.
|
 |
|
|
|
|
 |
H.C.Korswagen,
A.M.van der Linden,
and
R.H.Plasterk
(1998).
G protein hyperactivation of the Caenorhabditis elegans adenylyl cyclase SGS-1 induces neuronal degeneration.
|
| |
EMBO J, 17,
5059-5065.
|
 |
|
|
|
|
 |
J.H.Hurley
(1998).
The adenylyl and guanylyl cyclase superfamily.
|
| |
Curr Opin Struct Biol, 8,
770-777.
|
 |
|
|
|
|
 |
J.J.Dumas,
and
D.G.Lambright
(1998).
Gs alpha meets its target--shedding light on a key signal transduction event.
|
| |
Structure, 6,
407-411.
|
 |
|
|
|
|
 |
J.J.Tesmer,
and
S.R.Sprang
(1998).
The structure, catalytic mechanism and regulation of adenylyl cyclase.
|
| |
Curr Opin Struct Biol, 8,
713-719.
|
 |
|
|
|
|
 |
M.Natochin,
and
N.O.Artemyev
(1998).
A single mutation Asp229 --> Ser confers upon Gs alpha the ability to interact with regulators of G protein signaling.
|
| |
Biochemistry, 37,
13776-13780.
|
 |
|
|
|
|
 |
N.P.Skiba,
and
H.E.Hamm
(1998).
How Gsalpha activates adenylyl cyclase.
|
| |
Nat Struct Biol, 5,
88-92.
|
 |
|
|
|
|
 |
S.J.Gamblin,
and
S.J.Smerdon
(1998).
GTPase-activating proteins and their complexes.
|
| |
Curr Opin Struct Biol, 8,
195-201.
|
 |
|
|
|
|
 |
T.Mitterauer,
M.Hohenegger,
W.J.Tang,
C.Nanoff,
and
M.Freissmuth
(1998).
The C2 catalytic domain of adenylyl cyclase contains the second metal ion (Mn2+) binding site.
|
| |
Biochemistry, 37,
16183-16191.
|
 |
|
|
|
|
 |
W.Liu,
and
J.K.Northup
(1998).
The helical domain of a G protein alpha subunit is a regulator of its effector.
|
| |
Proc Natl Acad Sci U S A, 95,
12878-12883.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
| |